- Home
- BRX vs HALO Comparison
BRX vs HALO Comparison
Compare BRX & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRX | HALO |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 7.4B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | BRX | HALO |
|---|---|---|
| Price | $26.39 | $68.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $29.82 | ★ $73.33 |
| AVG Volume (30 Days) | ★ 3.0M | 2.3M |
| Earning Date | 02-09-2026 | 11-03-2025 |
| Dividend Yield | ★ 4.67% | N/A |
| EPS Growth | N/A | ★ 56.68 |
| EPS | 1.08 | ★ 4.74 |
| Revenue | ★ $1,346,289,000.00 | $1,242,852,000.00 |
| Revenue This Year | $7.62 | $34.83 |
| Revenue Next Year | $4.41 | $24.84 |
| P/E Ratio | $24.41 | ★ $14.44 |
| Revenue Growth | 5.75 | ★ 31.19 |
| 52 Week Low | $22.29 | $46.76 |
| 52 Week High | $28.61 | $79.50 |
Technical Indicators
Market Signals| Indicator | BRX | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 56.95 | 57.58 |
| Support Level | $25.58 | $61.23 |
| Resistance Level | $26.19 | $69.28 |
| Average True Range (ATR) | 0.41 | 1.72 |
| MACD | 0.13 | 0.66 |
| Stochastic Oscillator | 97.15 | 89.20 |
Price Performance
Historical ComparisonAbout BRX Brixmor Property Group Inc.
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.